Ethical Considerations in the Advent of 3D Printing Technology in Healthcare

The emergence of 3D printing technology in healthcare has ushered in a new era of personalized medical solutions. However, alongside its promises, this technology also introduces several critical challenges that demand attention. This research investigates the implications of 3D printing on patient safety, intellectual property, equity, data security, informed consent, and the roles of healthcare professionals. 3D printing has opened up remarkable opportunities in the creation of medical devices, implants, and prosthetics. Nevertheless, the potential for errors during the manufacturing process poses a significant concern. Ensuring the safety and reliability of 3D-printed medical products becomes paramount, as any defects or inaccuracies could have severe consequences on patient health and well-being. The accessibility of 3D printing technology raises apprehensions regarding intellectual property rights and regulatory standards. The possibility of replicating medical devices and pharmaceuticals may lead to patent infringements and pose difficulties in enforcing regulatory compliance. Striking a balance between innovation and protection of intellectual property becomes crucial in fostering a thriving 3D printing healthcare ecosystem. While 3D printing holds to democratize healthcare by offering personalized medical solutions, it also has the potential to exacerbate existing disparities in healthcare access. The cost of 3D printing technology and related services might prove prohibitive for certain communities, thereby widening the gap in access to advanced medical treatments. Addressing these disparities and ensuring equitable access to 3D printing healthcare solutions must be a priority for healthcare policymakers and stakeholders. The integration of 3D printing in healthcare necessitates the utilization and storage of sensitive patient data. However, ethical concerns emerge around the security and privacy of this data. Any breaches or misuse of patient information could not only compromise patient confidentiality but also erode trust in healthcare systems. Implementing robust data security measures and respecting patient privacy rights are essential to maintain public trust in 3D printing healthcare applications. As 3D printing enables the production of custom medical devices and implants, obtaining informed consent from patients becomes increasingly complex. Patients must comprehend the risks, benefits, and uncertainties associated with these personalized treatments to make autonomous decisions about their healthcare. Healthcare providers must develop comprehensive strategies to ensure adequate patient education and empowerment during the informed consent process

Medical Cyber-Physical Systems Development: A Forensics-Driven Approach

The synthesis of technology and the medical industry has partly contributed to the increasing interest in Medical Cyber-Physical Systems (MCPS). While these systems provide benefits to patients and professionals, they also introduce new attack vectors for malicious actors (e.g. financially-and/or criminally-motivated actors). A successful breach involving a MCPS can impact patient data and system availability. The complexity and operating requirements of a MCPS complicates digital investigations. Coupling this information with the potentially vast amounts of information that a MCPS produces and/or has access to is generating discussions on, not only, how to compromise these systems but, more importantly, how to investigate these systems. The paper proposes the integration of forensics principles and concepts into the design and development of a MCPS to strengthen an organization's investigative posture. The framework sets the foundation for future research in the refinement of specific solutions for MCPS investigations.Comment: This is the pre-print version of a paper presented at the 2nd International Workshop on Security, Privacy, and Trustworthiness in Medical Cyber-Physical Systems (MedSPT 2017

Reviewing the Drivers and Challenges in RFID Implementation in the Pharmaceutical Supply Chain

Counterfeiting is a global phenomenon that poses a serious financial threat to the pharmaceutical industry and more importantly jeopardizes public safety and security. Different measures, including new laws and regulations, have been put in place to mitigate the threat and tighten control in the pharmaceuticals supply chain. However, it appears that the most promising countermeasure is track-and-trace technology such as electronic-pedigree (E-pedigree) with Radio Frequency Identification (RFID) technology. In this study we present a framework exploring the antecedents and consequences of RFID applications in the pharmaceutical supply chain. The framework proposes that counterfeiting and E-pedigree regulation will drive the implementation of RFID in the pharmaceutical supply chain, which in turn provides strategic and operational benefits that enable competitive advantage. Meanwhile, the implementation of RFID requires overcoming many operational, technical and financial challenges. The framework provides a springboard that future study can explore using empirical data

Southern regionalisms, Global agendas: Innovating inclusive access to health, medicines and social protection in a context of social inequity

This Policy Brief highlights key findings from an ESRC (Economic and Social Research Council) Department for International Development-funded international social policy research project examining the scope for enhancing the contributions of Southern multilateral regional organisations to inclusive social development in low-income contexts. Questions guiding the project were: 1 Are social policies and programmes of action on a regional scale by Southern regional groupings of countries instituting approaches for accessing health and medicines that meet the needs of all? 2 What scope is there for strengthening regional health and social policy in the interests of poverty reduction, social equity and inclusive development? 3 What needs to be done to strengthen regional approaches and policies in support of equitable access to health, medicines and social protection? The principal focus of research was the regional health policies of the Southern African Development Community (SADC) and the Union of South American Nations (UNASUR). This is because SADC and UNASUR have clear mandates in relation to health (and other social policies), and include many of the world’s most impoverished populations, for whom unfavourable access to basic health care and medicines is both a persistent obstacle and a key social determinant of morbidity and mortality